The US cardiac assist device market will continue to experience growth after recovering from the impact of the COVID-19 pandemic. The market will be driven by expanded use of cardiac assist devices…
The European vascular access device market is well-established and will grow marginally over the forecast period. Unit sales will be supported by steady growth in the underlying patient population…
The Asia Pacific TEO device market will see moderate growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data, increasing access to the TEO…
The European PV device market will grow modestly over the forecast period, driven by increasing adoption of drug-eluting products as more clinical evidence for these technologies emerges, rising…
The US heart valve device market will continue to experience rapid growth, largely driven by the adoption of THV devices. Clinical investigations continue to generate positive results and propel…
The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However…
The European PV device will grow modestly through 2032. Market expansion will be driven by an increasing PAD patient pool, adoption of drug-eluting technologies, and a rising preference for the…
The Japanese PV device market will continue to experience modest growth through 2032 primarily due to growth in the endovascular procedure volumes along with the rising adoption of premium-priced…
The European cardiac assist market will continue to experience modest growth through 2032 after recovering from the impact of COVID-19. Growth will primarily be driven by the temporary VAD devices…
The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, an expanding patient population, and rising adoption of premium-priced drug-…
The European TEO device market will see modest growth over the forecast period driven by growing adoption of minimally invasive treatment options like embolization. Additionally, the market will…
The US neurovascular device market will see moderate growth through 2032 driven by the growing adoption of thrombectomy for managing acute ischemic stroke, the launch of new embolization and…
The Asia Pacific market for aortic repair device market will expand at a modest rate over the forecast period, driven primarily by endovascular procedure volume growth and continued development and…
The US EP mapping and ablation device market will experience moderate growth through 2032, with trends varying by device segment. The COVID-19 pandemic had a significant impact on some EP ablation…
The US TEO device market will expand at a moderate rate over the forecast period after recovering from the impact of COVID-19. The market factors contributing to this growth will include the…